216 related articles for article (PubMed ID: 25010268)
1. Effects of human SAMHD1 polymorphisms on HIV-1 susceptibility.
White TE; Brandariz-Nuñez A; Valle-Casuso JC; Knowlton C; Kim B; Sawyer SL; Diaz-Griffero F
Virology; 2014 Jul; 460-461():34-44. PubMed ID: 25010268
[TBL] [Abstract][Full Text] [Related]
2. Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1.
White TE; Brandariz-Nuñez A; Valle-Casuso JC; Amie S; Nguyen L; Kim B; Brojatsch J; Diaz-Griffero F
Virology; 2013 Feb; 436(1):81-90. PubMed ID: 23158101
[TBL] [Abstract][Full Text] [Related]
3. Vpx overcomes a SAMHD1-independent block to HIV reverse transcription that is specific to resting CD4 T cells.
Baldauf HM; Stegmann L; Schwarz SM; Ambiel I; Trotard M; Martin M; Burggraf M; Lenzi GM; Lejk H; Pan X; Fregoso OI; Lim ES; Abraham L; Nguyen LA; Rutsch F; König R; Kim B; Emerman M; Fackler OT; Keppler OT
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2729-2734. PubMed ID: 28228523
[TBL] [Abstract][Full Text] [Related]
4. Role of SAMHD1 nuclear localization in restriction of HIV-1 and SIVmac.
Brandariz-Nuñez A; Valle-Casuso JC; White TE; Laguette N; Benkirane M; Brojatsch J; Diaz-Griffero F
Retrovirology; 2012 Jun; 9():49. PubMed ID: 22691373
[TBL] [Abstract][Full Text] [Related]
5. Host SAMHD1 protein restricts endogenous reverse transcription of HIV-1 in nondividing macrophages.
Mahboubi B; Gavegnano C; Kim DH; Schinazi RF; Kim B
Retrovirology; 2018 Oct; 15(1):69. PubMed ID: 30316304
[TBL] [Abstract][Full Text] [Related]
6. The ribonuclease activity of SAMHD1 is required for HIV-1 restriction.
Ryoo J; Choi J; Oh C; Kim S; Seo M; Kim SY; Seo D; Kim J; White TE; Brandariz-Nuñez A; Diaz-Griffero F; Yun CH; Hollenbaugh JA; Kim B; Baek D; Ahn K
Nat Med; 2014 Aug; 20(8):936-41. PubMed ID: 25038827
[TBL] [Abstract][Full Text] [Related]
7. Anti-HIV host factor SAMHD1 regulates viral sensitivity to nucleoside reverse transcriptase inhibitors via modulation of cellular deoxyribonucleoside triphosphate (dNTP) levels.
Amie SM; Daly MB; Noble E; Schinazi RF; Bambara RA; Kim B
J Biol Chem; 2013 Jul; 288(28):20683-91. PubMed ID: 23744077
[TBL] [Abstract][Full Text] [Related]
8. Vpx requires active cellular dNTP biosynthesis to effectively counteract the anti-lentivirus activity of SAMHD1 in macrophages.
Bowen NE; Tao S; Cho YJ; Schinazi RF; Kim B
J Biol Chem; 2023 Aug; 299(8):104984. PubMed ID: 37390988
[TBL] [Abstract][Full Text] [Related]
9. Viral protein X reduces the incorporation of mutagenic noncanonical rNTPs during lentivirus reverse transcription in macrophages.
Oo A; Kim DH; Schinazi RF; Kim B
J Biol Chem; 2020 Jan; 295(2):657-666. PubMed ID: 31806704
[TBL] [Abstract][Full Text] [Related]
10. The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals.
Yu H; Usmani SM; Borch A; Krämer J; Stürzel CM; Khalid M; Li X; Krnavek D; van der Ende ME; Osterhaus AD; Gruters RA; Kirchhoff F
Retrovirology; 2013 Mar; 10():27. PubMed ID: 23497283
[TBL] [Abstract][Full Text] [Related]
11. HIV-2 Depletes CD4 T Cells through Pyroptosis despite Vpx-Dependent Degradation of SAMHD1.
Luo X; Herzig E; Doitsh G; Grimmett ZW; Muñoz-Arias I; Greene WC
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578293
[TBL] [Abstract][Full Text] [Related]
12. HIV-2 Vpx neutralizes host restriction factor SAMHD1 to promote viral pathogenesis.
Mohamed A; Bakir T; Al-Hawel H; Al-Sharif I; Bakheet R; Kouser L; Murugaiah V; Al-Mozaini M
Sci Rep; 2021 Oct; 11(1):20984. PubMed ID: 34697376
[TBL] [Abstract][Full Text] [Related]
13. SAMHD1 specifically affects the antiviral potency of thymidine analog HIV reverse transcriptase inhibitors.
Ballana E; Badia R; Terradas G; Torres-Torronteras J; Ruiz A; Pauls E; Riveira-Muñoz E; Clotet B; Martí R; Esté JA
Antimicrob Agents Chemother; 2014 Aug; 58(8):4804-13. PubMed ID: 24913159
[TBL] [Abstract][Full Text] [Related]
14. SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interferons.
St Gelais C; de Silva S; Amie SM; Coleman CM; Hoy H; Hollenbaugh JA; Kim B; Wu L
Retrovirology; 2012 Dec; 9():105. PubMed ID: 23231760
[TBL] [Abstract][Full Text] [Related]
15. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx.
Laguette N; Sobhian B; Casartelli N; Ringeard M; Chable-Bessia C; Ségéral E; Yatim A; Emiliani S; Schwartz O; Benkirane M
Nature; 2011 May; 474(7353):654-7. PubMed ID: 21613998
[TBL] [Abstract][Full Text] [Related]
16. Degradation of SAMHD1 by Vpx Is Independent of Uncoating.
Jáuregui P; Logue EC; Schultz ML; Fung S; Landau NR
J Virol; 2015 May; 89(10):5701-13. PubMed ID: 25762741
[TBL] [Abstract][Full Text] [Related]
17. The ability of SAMHD1 to block HIV-1 but not SIV requires expression of MxB.
Buffone C; Kutzner J; Opp S; Martinez-Lopez A; Selyutina A; Coggings SA; Studdard LR; Ding L; Kim B; Spearman P; Schaller T; Diaz-Griffero F
Virology; 2019 May; 531():260-268. PubMed ID: 30959264
[TBL] [Abstract][Full Text] [Related]
18. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates.
Lahouassa H; Daddacha W; Hofmann H; Ayinde D; Logue EC; Dragin L; Bloch N; Maudet C; Bertrand M; Gramberg T; Pancino G; Priet S; Canard B; Laguette N; Benkirane M; Transy C; Landau NR; Kim B; Margottin-Goguet F
Nat Immunol; 2012 Feb; 13(3):223-228. PubMed ID: 22327569
[TBL] [Abstract][Full Text] [Related]
19. Interferon block to HIV-1 transduction in macrophages despite SAMHD1 degradation and high deoxynucleoside triphosphates supply.
Dragin L; Nguyen LA; Lahouassa H; Sourisce A; Kim B; Ramirez BC; Margottin-Goguet F
Retrovirology; 2013 Mar; 10():30. PubMed ID: 23497353
[TBL] [Abstract][Full Text] [Related]
20. Host SAMHD1 protein promotes HIV-1 recombination in macrophages.
Nguyen LA; Kim DH; Daly MB; Allan KC; Kim B
J Biol Chem; 2014 Jan; 289(5):2489-96. PubMed ID: 24352659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
